HARBOUR BIOMED
Harbour BioMed is a developer of bio-therapeutics aimed at immuno-oncology and inflammatory diseases. The company engages in discovery and development programs that are centered around two patented transgenic mouse platforms for generating both fully human monoclonal antibodies (H2L2) and heavy chain only antibodies (HCAb) based immune cell engager (HBICETM) bispecific antibodies, thereby enabling medical professionals to generate potential therapeutic antibodies and accelerate drug discovery and development.
HARBOUR BIOMED
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2016-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.harbourbiomed.com
Total Employee:
51+
Status:
Active
Contact:
+86-21-51370990
Email Addresses:
[email protected]
Total Funding:
312.8 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Domain Not Resolving Mobile Non Scaleable Content Nginx Euro Microsoft Azure DNS PHP
Similar Organizations
Eidos Therapeutics
Eidos Therapeutics is a clinical-stage biotech company developing novel, genetically targeted therapies to improve the lives of patients.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
I-Mab Biopharma
I-Mab is a dynamic and fast-growing global biotech company exclusively focused on developing innovative biologics.
IASO Biotherapeutics
IASO Biotherapeutics is a biopharmaceutical company focused on the development of cell therapies in the field of oncology.
Immutep
Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.
InventisBio
InventisBio is a clinical-stage biotech company dedicated to the research and development of innovative small-molecule drugs.
Lianchuang Biomedicine
Lianchuang Bio is a pharmaceutical company that offers R&D, production, and marketing of advanced pharmaceutical intermediates.
Palisade Bio
Palisade Bio is a clinical-stage biopharmaceutical company developing novel therapies for acute and chronic gastrointestinal complications.
Sirnaomics
Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.
TOT BIOPHARM
TOT BIOPHARM is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative oncology drugs.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2016-12-19 | Harbour Antibodies | Harbour Antibodies acquired by Harbour Biomed | N/A |
Investors List
Hudson Bay Capital Management
Hudson Bay Capital Management investment in Series C - Harbour Biomed
Greater Bay Area Homeland Development Fund
Greater Bay Area Homeland Development Fund investment in Series C - Harbour Biomed
Octagon Capital Partners
Octagon Capital Partners investment in Series C - Harbour Biomed
Country Garden
Country Garden investment in Series C - Harbour Biomed
OrbiMed
OrbiMed investment in Series C - Harbour Biomed
ShenZhen GTJA Investment Group
ShenZhen GTJA Investment Group investment in Series C - Harbour Biomed
SK Holdings
SK Holdings investment in Series B - Harbour Biomed
Zhejiang University
Zhejiang University investment in Series B - Harbour Biomed
Greater Bay Area Homeland Development Fund
Greater Bay Area Homeland Development Fund investment in Series B - Harbour Biomed
GIC
GIC investment in Series B - Harbour Biomed
Key Employee Changes
| Date | New article |
|---|---|
| 2022-04-14 | Harbour BioMed Appoints Dr. Humphrey Gardner as Chief Medical Officer |
| 2021-12-02 | Harbour BioMed Appoints Mr. Weihao Xu as Chief Strategy Officer |
| 2021-07-20 | Harbour BioMed Appoints Yingying Chen, PhD, as Chief Financial Officer |
Official Site Inspections
http://www.harbourbiomed.com Semrush global rank: 3.95 M Semrush visits lastest month: 3.16 K
- Host name: ec2-140-179-40-210.cn-north-1.compute.amazonaws.com.cn
- IP address: 140.179.40.210
- Location: Beijing China
- Latitude: 39.9288
- Longitude: 116.3889
- Timezone: Asia/Shanghai
More informations about "Harbour Biomed" on Search Engine
HARBOUR BIOMED | LinkedIn
Harbour BioMed (HKEX: 02142) is a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics focusing …See details»
Harbour BioMed Appoints Dr. Humphrey Gardner as Chief …
Harbour BioMed (HKEX: 02142) is a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics focusing …See details»
Harbour Biomed - Crunchbase Company Profile & Funding
Harbour BioMed is a developer of bio-therapeutics aimed at immuno-oncology and inflammatory diseases. The company engages in discovery and development programs …See details»
Harbour BioMed Reports Full Year 2021 Financial Results: Two …
Mar 25, 2022 Harbour BioMed (HKEX: 02142) is a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody …See details»
Harbour BioMed Acquires Harbour Antibodies to Create Global, …
Dec 19, 2016 The new company plans to leverage Harbour Antibodies' patented transgenic mouse platforms to build an internal portfolio of next generation therapeutic …See details»
Harbour BioMed Announces 2023 Interim Results-hbm holdings
Aug 28, 2023 Harbour BioMed (“HBM”, or the "Company”; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and …See details»
Harbour BioMed Reports Full Year 2021 Financial Results: …
Mar 25, 2022 Harbour BioMed (HKEX: 02142) is a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody …See details»
Harbour BioMed and The Wistar Institute Join Forces to Advance …
Harbour BioMed and The Wistar Institute announced today that they have entered into a multi-year, multifaceted research collaboration to co-discover novel antibodies for the …See details»
Pharma Boardroom-hbm holdings
March 04, 2019. Harbour BioMed is a fast-growing global biotech company with facilities in Rotterdam, Boston and Shanghai. The company is laser-focused on developing both …See details»
Technology Platforms - hbm holdings
We are one of the leading biotech companies in the world capable of integrating single B cell high throughput screening and fully human antibody transgenic mouse platform. This …See details»
Harbour BioMed and PPD Form Strategic Collaboration to …
Aug 27, 2019 Harbour BioMed is a global, clinical stage biopharmaceutical company developing innovative therapeutics in the fields of immuno-oncology and inflammatory …See details»
Mount Sinai and Harbour BioMed Collaborate to Advance Novel ...
(March 06, 2020) Mount Sinai Health System and Harbour BioMed (HBM) have entered into a multi-year, multifaceted collaboration to develop novel, fully human antibodies for …See details»
BioMap collaborates with Harbour BioMed to discover a novel …
Oct 10, 2022 Harbour BioMed is a globally recognized biopharmaceuticals firm focusing on pioneering antibody therapies in oncology and immunology spaces. Boasting a world …See details»
Presentations and Events - hbm holdings - HARBOUR BIOMED
HOME / Investor Relations / Presentations and Events. All 2024 2023 2022 2021. Mar 28, 2024. 2023 Annual Results Online Conference. Presentation. Dec 15, 2023. HBM 9033 …See details»
Harbour Biomed - Funding, Financials, Valuation & Investors
Harbour Biomed has raised a total of. $312.8M. in funding over 5 rounds. Their latest funding was raised on Jul 9, 2020 from a Series C round. Harbour Biomed is registered …See details»
Financials - hbm holdings - HARBOUR BIOMED
Corporate Governance Stock Information Disclosure Financials Presentations and Events Contact IR. HOME / Investor Relations / Financials. All 2024 2023 2022 2021. ANNUAL …See details»
Our Locations - hbm holdings
Address: C18, 2F, Tower A, 420 Fenglin Road, Xuhui District, Shanghai, China 200032 Tel: +86-21-53399123See details»
Harbour BioMed | CipherBio
Harbour BioMed is an Immune-Driven Global Bio-therapeutics Company discovering, developing and delivering Innovative Therapeutics for Oncology and Immunology. The …See details»
Harbour Biomed - Contacts, Employees, Board Members, …
Harbour BioMed is a clinical stage biopharmaceutical company developing innovative therapeutics in the fields of immuno-oncology.See details»